• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Virus load and incidence of olfactory, gustatory, respiratory, gastrointestinal disorders in COVID-19 patients: A retrospective cohort study.COVID-19 患者病毒载量和嗅觉、味觉、呼吸、胃肠道紊乱发生率:一项回顾性队列研究。
Clin Otolaryngol. 2021 Nov;46(6):1331-1338. doi: 10.1111/coa.13844. Epub 2021 Aug 16.
2
COVID-19 Viral Load in the Severity of and Recovery From Olfactory and Gustatory Dysfunction.COVID-19 病毒载量与嗅觉和味觉功能障碍严重程度及恢复的关系。
Laryngoscope. 2020 Nov;130(11):2680-2685. doi: 10.1002/lary.29056. Epub 2020 Sep 8.
3
Prevalence and recovery time of olfactory and gustatory dysfunction in hospitalized patients with COVID‑19 in Wuhan, China.中国武汉住院 COVID-19 患者嗅觉和味觉障碍的患病率和恢复时间。
Int J Infect Dis. 2020 Nov;100:507-512. doi: 10.1016/j.ijid.2020.09.039. Epub 2020 Sep 17.
4
Olfactory and Gustatory Outcomes in COVID-19: A Prospective Evaluation in Nonhospitalized Subjects.COVID-19 患者的嗅觉和味觉结果:非住院患者的前瞻性评估。
Otolaryngol Head Neck Surg. 2020 Dec;163(6):1144-1149. doi: 10.1177/0194599820939538. Epub 2020 Jun 30.
5
Eight-month follow-up of olfactory and gustatory dysfunctions in recovered COVID-19 patients.新冠康复患者嗅觉和味觉障碍的 8 个月随访。
Am J Otolaryngol. 2021 Jul-Aug;42(4):103065. doi: 10.1016/j.amjoto.2021.103065. Epub 2021 Apr 20.
6
Long-term follow-up of olfactory and gustatory dysfunction in COVID-19: 6 months case-control study of health workers.新冠长期嗅觉和味觉功能障碍的随访:6 个月医护人员病例对照研究。
Eur Arch Otorhinolaryngol. 2021 Dec;278(12):4831-4837. doi: 10.1007/s00405-021-06764-y. Epub 2021 Mar 28.
7
Long-term Consequences of COVID-19: Chemosensory Disorders.COVID-19 的长期后果:嗅觉和味觉障碍。
Curr Allergy Asthma Rep. 2023 Feb;23(2):111-119. doi: 10.1007/s11882-022-01062-x. Epub 2022 Dec 27.
8
Long-standing gustatory and olfactory dysfunction in COVID-19 patients: a prospective study.新冠病毒患者长期存在的味觉和嗅觉功能障碍:一项前瞻性研究。
Eur Arch Otorhinolaryngol. 2022 Sep;279(9):4633-4640. doi: 10.1007/s00405-022-07428-1. Epub 2022 Jun 29.
9
Objective gustatory and olfactory dysfunction in COVID-19 patients: a prospective cross-sectional study.目的:研究 COVID-19 患者味觉和嗅觉功能障碍:一项前瞻性横断面研究。
Eur Arch Otorhinolaryngol. 2021 Sep;278(9):3325-3332. doi: 10.1007/s00405-020-06590-8. Epub 2021 Jan 20.
10
Olfactory and gustatory dysfunctions in 100 patients hospitalized for COVID-19: sex differences and recovery time in real-life.100例因新冠肺炎住院患者的嗅觉和味觉功能障碍:现实生活中的性别差异和恢复时间
Eur Arch Otorhinolaryngol. 2020 Dec;277(12):3519-3523. doi: 10.1007/s00405-020-06102-8. Epub 2020 Jun 4.

引用本文的文献

1
Magnetic resonance spectroscopy findings of brain olfactory areas in patients with COVID-19-related anosmia: A preliminary comparative study.新型冠状病毒肺炎相关嗅觉减退患者脑嗅觉区域的磁共振波谱研究:一项初步比较研究
World J Otorhinolaryngol Head Neck Surg. 2023 Aug 28;10(2):105-112. doi: 10.1002/wjo2.132. eCollection 2024 Jun.
2
Liver injury in COVID-19: an insight into pathobiology and roles of risk factors.COVID-19 相关肝损伤:对发病机制及危险因素作用的深入了解。
Virol J. 2024 Mar 15;21(1):65. doi: 10.1186/s12985-024-02332-y.
3
Taste loss as a distinct symptom of COVID-19: a systematic review and meta-analysis.味觉丧失是 COVID-19 的一个独特症状:系统评价和荟萃分析。
Chem Senses. 2023 Jan 1;48. doi: 10.1093/chemse/bjad043.
4
SARS-Cov-2 Cycle Threshold Value and Olfactory Dysfunction in COVID-19 Patients.新冠病毒感染患者中新冠病毒2型的循环阈值与嗅觉功能障碍
Iran J Otorhinolaryngol. 2023 Sep;35(130):263-273. doi: 10.22038/IJORL.2023.71462.3429.
5
Ct, polymorphism, and laboratory biomarkers for predicting chemosensory dysfunctions and mortality in COVID-19.用于预测COVID-19患者化学感觉功能障碍和死亡率的CT、多态性及实验室生物标志物
Future Sci OA. 2023 Mar 9;9(2):FSO838. doi: 10.2144/fsoa-2022-0082. eCollection 2023 Feb.
6
The Prevalence and Implications of Olfactory/Gustatory Dysfunctions among Adult COVID-19 Patients: A Retrospective Cohort Multiethnic Populations Study.成年新冠病毒肺炎患者嗅觉/味觉功能障碍的患病率及其影响:一项回顾性队列多民族人群研究
Trop Med Infect Dis. 2022 Jun 23;7(7):115. doi: 10.3390/tropicalmed7070115.
7
Physiological plausibility of lower viral load in patients with COVID-19 and olfactory/gustatory dysfunction.新冠病毒疾病(COVID-19)合并嗅觉/味觉功能障碍患者病毒载量较低的生理合理性
Clin Otolaryngol. 2022 Mar;47(2):397-398. doi: 10.1111/coa.13892. Epub 2021 Nov 29.
8
Gastrointestinal manifestations and possible mechanisms of COVID-19 in different periods.新型冠状病毒肺炎不同时期的胃肠道表现及可能机制
J Dig Dis. 2021 Dec;22(12):683-694. doi: 10.1111/1751-2980.13065. Epub 2021 Dec 12.
9
Taste loss as a distinct symptom of COVID-19: A systematic review and meta-analysis.味觉丧失作为新冠病毒病的一种独特症状:一项系统综述和荟萃分析。
medRxiv. 2021 Oct 9:2021.10.09.21264771. doi: 10.1101/2021.10.09.21264771.
10
Features of Pathobiology and Clinical Translation of Approved Treatments for Coronavirus Disease 2019.获批治疗 2019 冠状病毒病的病理生物学和临床转化特征。
Intervirology. 2022;65(3):119-133. doi: 10.1159/000520234. Epub 2021 Oct 25.

本文引用的文献

1
Recovery of olfactory and gustatory dysfunctions in coronavirus disease 2019 patients: a prospective cohort study.2019冠状病毒病患者嗅觉和味觉功能障碍的恢复:一项前瞻性队列研究
J Laryngol Otol. 2022 Feb 9:1-8. doi: 10.1017/S0022215121003935.
2
The Association of Smell and Taste Dysfunction with COVID19, And Their Functional Impacts.嗅觉和味觉功能障碍与 COVID-19 的关联及其功能影响。
Indian J Otolaryngol Head Neck Surg. 2022 Oct;74(Suppl 2):2847-2852. doi: 10.1007/s12070-020-02330-w. Epub 2021 Jan 23.
3
Association of SARS-CoV-2 genomic load trends with clinical status in COVID-19: A retrospective analysis from an academic hospital center in New York City.SARS-CoV-2 基因组载量趋势与 COVID-19 临床状态的关联:来自纽约市一所学术医院中心的回顾性分析。
PLoS One. 2020 Nov 17;15(11):e0242399. doi: 10.1371/journal.pone.0242399. eCollection 2020.
4
Using Anti-SARS-CoV-2 IgG and IgM Antibodies to Detect Outpatient Cases with Olfactory and Taste Disorders Suspected as Mild Form of COVID-19: a Retrospective Survey.使用抗SARS-CoV-2 IgG和IgM抗体检测疑似轻症COVID-19的嗅觉和味觉障碍门诊病例:一项回顾性调查。
SN Compr Clin Med. 2020;2(12):2554-2560. doi: 10.1007/s42399-020-00623-3. Epub 2020 Nov 3.
5
COVID-19 Viral Load in the Severity of and Recovery From Olfactory and Gustatory Dysfunction.COVID-19 病毒载量与嗅觉和味觉功能障碍严重程度及恢复的关系。
Laryngoscope. 2020 Nov;130(11):2680-2685. doi: 10.1002/lary.29056. Epub 2020 Sep 8.
6
A Systematic Review of the Clinical Utility of Cycle Threshold Values in the Context of COVID-19.COVID-19背景下循环阈值临床效用的系统评价
Infect Dis Ther. 2020 Sep;9(3):573-586. doi: 10.1007/s40121-020-00324-3. Epub 2020 Jul 28.
7
Distribution of SARS-CoV-2 PCR Cycle Threshold Values Provide Practical Insight Into Overall and Target-Specific Sensitivity Among Symptomatic Patients.SARS-CoV-2 PCR 循环阈值分布为有症状患者的整体和目标特异性灵敏度提供了实用见解。
Am J Clin Pathol. 2020 Sep 8;154(4):479-485. doi: 10.1093/ajcp/aqaa133.
8
The Raw Cycle Threshold Values From Reverse-transcription Polymerase Chain Reaction Detection Are Not Viral Load Quantitation Units.逆转录聚合酶链反应检测得到的原始循环阈值并非病毒载量定量单位。
Clin Infect Dis. 2021 Apr 26;72(8):1489-1490. doi: 10.1093/cid/ciaa830.
9
Clinical characteristics of coronavirus disease (COVID-19) patients with gastrointestinal symptoms: A report of 164 cases.胃肠道症状的新型冠状病毒病 (COVID-19) 患者的临床特征:164 例报告。
Dig Liver Dis. 2020 Oct;52(10):1076-1079. doi: 10.1016/j.dld.2020.04.034. Epub 2020 May 8.
10
Association Between Orthonasal Olfaction and Chemosensory Perception in Patients With Smell Loss.嗅觉丧失患者的鼻前嗅觉与化学感觉感知之间的关联。
Laryngoscope. 2020 Sep;130(9):2213-2219. doi: 10.1002/lary.28773. Epub 2020 Jun 3.

COVID-19 患者病毒载量和嗅觉、味觉、呼吸、胃肠道紊乱发生率:一项回顾性队列研究。

Virus load and incidence of olfactory, gustatory, respiratory, gastrointestinal disorders in COVID-19 patients: A retrospective cohort study.

机构信息

Department of Otorhinolaryngology, Neuroscience Research Center, School of Medicine, Golestan University of Medical Sciences, Gorgan, Iran.

Department of Health Management and Social Development Research Center, Faculty of Health, Golestan University of Medical Sciences, Gorgan, Iran.

出版信息

Clin Otolaryngol. 2021 Nov;46(6):1331-1338. doi: 10.1111/coa.13844. Epub 2021 Aug 16.

DOI:10.1111/coa.13844
PMID:34358409
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8444685/
Abstract

OBJECTIVES

This study investigated the relationship between viral load and the incidence of olfactory and gustatory dysfunction (OD and GD), the incidence of respiratory and gastrointestinal symptoms and the recovery of OD and GD in COVID-19 patients.

DESIGN

A retrospective cohort study.

SETTING AND PARTICIPANTS

This study was conducted on 599 outpatients' cases in Golestan province between February and June 2020.

MAIN OUTCOME MEASURES

The incidence, severity (complete or partial) and recovery time of OD and GD and their associations with cycle threshold (CT) values of SARS-CoV-2 polymerase chain reaction were assessed.

RESULTS

The mean age of patients was 38.27 ± 13.62 years. The incidence of general symptoms included myalgia 70.1%, headache 51.8%, fever 47.7% and dyspnoea 21.4%. 41.9% of patients had gastrointestinal symptoms, including abdominal pain 26.5%, diarrhoea 25.2%, nausea 20.5% and vomiting 12.9%. 12.2% of patients had comorbidity. The trimester recovery rates of OD and GD were 93.94% and 94.74% respectively. The mean recovery time of OD and GD was 14.56 ± 13.37 and 13.8 ± 3.77 days respectively. The mean CT value in all patients was 27.45 ± 4.55. There were significant associations between the mean of CT value with headache (p = 0.04), GD (p = 0.002) and OD (p = 0.001).

CONCLUSIONS

The finding of this study indicates a possible association between viral load with incidence of OD and GD in COVID-19 patient's cases and assures the recovery of OD/GD in these patients.

摘要

目的

本研究旨在探讨病毒载量与 COVID-19 患者嗅觉和味觉功能障碍(OD 和 GD)发生率、呼吸道和胃肠道症状发生率以及 OD 和 GD 恢复之间的关系。

设计

回顾性队列研究。

地点和参与者

本研究于 2020 年 2 月至 6 月在戈勒斯坦省对 599 例门诊患者进行。

主要观察指标

评估 OD 和 GD 的发生率、严重程度(完全或部分)和恢复时间及其与 SARS-CoV-2 聚合酶链反应循环阈值(CT)值的关系。

结果

患者的平均年龄为 38.27±13.62 岁。全身症状包括肌痛 70.1%、头痛 51.8%、发热 47.7%和呼吸困难 21.4%。41.9%的患者有胃肠道症状,包括腹痛 26.5%、腹泻 25.2%、恶心 20.5%和呕吐 12.9%。12.2%的患者有合并症。OD 和 GD 的三阶段恢复率分别为 93.94%和 94.74%。OD 和 GD 的平均恢复时间分别为 14.56±13.37 和 13.8±3.77 天。所有患者的平均 CT 值为 27.45±4.55。CT 值平均值与头痛(p=0.04)、GD(p=0.002)和 OD(p=0.001)之间存在显著相关性。

结论

本研究结果表明,病毒载量与 COVID-19 患者 OD 和 GD 的发生率之间可能存在关联,并可确保这些患者的 OD/GD 恢复。